LivingGLP1
Study S000565

JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity - a Randomized Controlled Trial

Registration

Registration
NCT06852391
Acronym
JOULE-MARS
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
RECRUITING
Enrollment
74
Start
2025-06-18
Primary completion
2027-12-31
Lead sponsor
McMaster University
Conditions
Obesity (Disorder)
Interventions
DRUG:Semaglutide Pen Injector; BEHAVIORAL:Behavioural Lifestyle Program (BLP)
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Measurement of Adaptive thermogenesis [6, 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.